z-logo
open-access-imgOpen Access
The Clinical Significance of Deglycosylated PD-L1 Level Detection Using 28-8 Monoclonal Antibody in Lung Adenocarcinoma
Author(s) -
Huiyu Wang,
Dawei Gu,
Datian Chen,
Jie Mei,
Xuejing Yang,
Jiong Ding,
Junying Xu,
Meilin Wang,
Chaoying Liu,
Dong Hua
Publication year - 2022
Publication title -
international journal of general medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.722
H-Index - 36
ISSN - 1178-7074
DOI - 10.2147/ijgm.s381530
Subject(s) - adenocarcinoma , medicine , lung cancer , monoclonal antibody , immunohistochemistry , lung , stage (stratigraphy) , clinical significance , adenocarcinoma of the lung , oncology , antibody , gastroenterology , pathology , immunology , cancer , biology , paleontology
The aim of this study was to explore the clinical significance of deglycosylated PD-L1 level and its correlation with EGFR and ALK mutation in lung adenocarcinoma.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here